Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.

Hou, Zhi-Jie

Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells. [electronic resource] - Oncotarget Mar 2015 - 6326-40 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1949-2553

10.18632/oncotarget.3436 doi


Animals
Antinematodal Agents--pharmacology
Antineoplastic Agents--pharmacology
Breast Neoplasms--drug therapy
Cell Line, Tumor
Cell Proliferation--drug effects
Female
Humans
MCF-7 Cells
Mebendazole--administration & dosage
Mice
Mice, Nude
Neoplastic Stem Cells--drug effects
Random Allocation
Xenograft Model Antitumor Assays